Jul 18, 2013
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.07 to $0.00.
The split itself did not change the total investment value.
Gene Biotherapeutics, Inc. (CRXM) trades on the Other OTC in the Biotechnology industry.
Gene Biotherapeutics, Inc. company overviewThe latest split shown was on July 18, 2013. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records one reverse split, on July 18, 2013.